The No Harm Act (H.R. 2387) would prohibit federal funds from being used for sex-trait altering treatments for minors and extend similar prohibitions to related regulatory actions, institutions, schools, and certain state programs. The bill creates civil action avenues for individuals to sue for violations, adds restrictions to inform consent and parental involvement, and strengthens protections for health care providers who refuse to participate in such treatments. It also broadens penalties and liability (including medical malpractice and damages) and amends existing law to exclude gender-affirming care from being considered “necessary to the health” in a way that would permit certain medical justifications. In short, the bill aims to restrict federal funding and support for gender-transition-related care for minors, reinforce parental rights, and provide legal remedies for violations.
Key Points
- 1Prohibits federal funds for sex-trait altering treatments for minors and bars funding to pay for, sponsor, or support such treatments; creates civil action rights for violators.
- 2Expands prohibitions to regulatory and subregulatory actions aimed at promoting sex-trait altering treatments for minors; provides civil action rights for violations.
- 3Amends federal law to ensure that certain health claims cannot rely on “necessity to health” to justify gender-transition care; broadens the definition of sex-trait altering treatments.
- 4Prohibits federal funding to medical institutions that provide sex-trait altering treatments to minors; requires parental consent and notifies parents for school-related provision of such treatments.
- 5Establishes strong protections for conscience rights of health care providers, requires informed consent, and creates liability avenues (including malpractice suits with treble damages) for harm caused by sex-trait altering treatments to minors.